Skip to main content
. 2024 Jun 28;119(12):2398–2407. doi: 10.14309/ajg.0000000000002924

Figure 5.

Figure 5.

Proportion of patients reporting the lowest severity level on the PGIS of dysphagia at baseline and weeks 12, 20, and 24. *Nominal P ≤ 0.05, **nominal P ≤ 0.01 dupilumab vs placebo. CI, confidence interval; PGIS, Patient Global Impression of Severity; qw, once weekly.